Abcellera Biologics Inc Working Capital to Net Assets Ratio
Abcellera Biologics Inc working capital to net assets ratio. Abcellera Biologics Inc (ABCL) has a Working Capital to Net Assets ratio of 69.9% as of June 2026. Working capital of $626.04 Million (current assets of $679.23 Million minus current liabilities of $53.19 Million) is measured against net assets of $896.02 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Abcellera Biologics Inc (2018–2025)
Working capital to net assets ratio of Abcellera Biologics Inc from 2018 to 2025. This chart shows how Abcellera Biologics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 69.9%, reflecting working capital of $626.04 Million against net assets of $896.02 Million USD. Explore Abcellera Biologics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Abcellera Biologics Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Abcellera Biologics Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Abcellera Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Abcellera Biologics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 68.7% | $663.92 Million | $966.90 Million | $728.23 Million | $64.31 Million | ▲ +4.8 pp |
| 2024 | 63.9% | $674.76 Million | $1.06 Billion | $751.37 Million | $76.61 Million | ▼ -1.5 pp |
| 2023 | 65.3% | $752.97 Million | $1.15 Billion | $871.99 Million | $119.01 Million | ▼ -8.2 pp |
| 2022 | 73.6% | $907.17 Million | $1.23 Billion | $1.03 Billion | $118.32 Million | ▼ -5.3 pp |
| 2021 | 78.9% | $809.12 Million | $1.03 Billion | $929.80 Million | $120.68 Million | ▼ -6.6 pp |
| 2020 | 85.5% | $709.84 Million | $830.51 Million | $813.33 Million | $103.49 Million | ▲ +39.2 pp |
| 2019 | 46.3% | $4.75 Million | $10.25 Million | $12.64 Million | $7.89 Million | ▼ -28.9 pp |
| 2018 | 75.2% | $8.73 Million | $11.61 Million | $15.16 Million | $6.43 Million | — |